Supplier News: Lotte Biologics, Thermo Fisher Scientific, Evonik, Aptar Pharma & ACG 

The latest from CDMOs, CMOs, and suppliers featuring Lotte Biologics, Thermo Fisher Scientific, Evonik, Aptar Pharma, and ACG.  

Biologics Manufacturing 
* Lotte Biologics Opens New Bio Campus, Signs Mfg Agreement 
* Thermo Fisher Launches Media for Adenovirus-Vaccine-Production
Formulation Development/Drug Product Manufacturing
* Evonik Produces First Batch of Pharma Lipids in Indiana Facility
Packaging 
* Aptar Pharma Adds Controlled Substance Capabilities
Appointments  
* ACG Appoints New Sales Director, North America 


Biologics Manufacturing 

Lotte Biologics Completes New Bio Campus, Signs Mfg Agreement 
Lotte Biologics, a Seoul, South Korea-headquartered CDMO of biologics, has completed its first biomanufacturing plant as part of its new Songdo Bio Campus in Incheon, South Korea and has announced a commercial manufacturing agreement with an undisclosed pharmaceutical company.  

The Songdo Bio Campus is being developed with a planned capacity of 360,000 liters across three plants, with the first facility providing 120,000 liters through eight 15,000-liter stainless-steel bioreactors with a total floor area of approximately 99,558 square meters. The new facility  obtained its use approval in June 2026, and the company is carrying out preparatory procedures for commercial production, such as equipment qualification and validation, and plans to begin full-scale commercial production in 2027. 

Under the commercial agreement, Lotte will provide integrated drug-substance and drug-product manufacturing services for products in the customer’s portfolio, with commercial production targeted to begin in 2027. 

Source: Lotte Biologics (manufacturing agreement) and Lotte Biologics (facility completion) 


Thermo Fisher Launches Media for Adenovirus-Vaccine-Production 
Thermo Fisher Scientific has launched a chemically defined and animal origin-free cell-culture medium designed to support suspension HEK293 cell growth and high-titer adenovirus production. The medium is designed to support vaccine developers from early process development through scale-up and manufacturing. 

Source: Thermo Fisher Scientific 


Formulation Development/Drug Product Manufacturing

Evonik Produces First Batch of Pharma Lipids in Indiana Facility
Evonik has manufactured its first batch of GMP-grade pharmaceutical lipids at its New Lipid Innovation Center in Lafayette, Indiana. Supported by the US government, the large-scale facility at Evonik’s Tippecanoe site will produce pharmaceutical lipids to enable the manufacture of advanced therapies in the US. Full capacity is scheduled to come on stream by mid-2027.

Evonik Vancouver Laboratories develops lipid nanoparticle formulations and supports clinical manufacturing, with an investment ongoing in a new GMP facility that was announced in August (August 2026) with production slated to begin in 2029. Late-stage clinical and commercial processes are transferred to Evonik’s site in Birmingham, Alabama, and sites in Dossenheim and Hanau, Germany, and now also the Tippecanoe site in Indiana supply lipids and adjuvants. The company’s Cambridge Innovation Satellite in Greater Boston, adds R&D capabilities.

Source: Evonik


Packaging 

Aptar Pharma Adds Controlled Substance Capabilities 
Aptar Pharma, a provider of drug delivery, dosing, protection technologies, and related services, has announced that its formulation, fill–finish services facility in Boonton, New Jersey, has been granted a controlled substances registration to authorize the handling, storage, manufacturing and testing of Schedule II and III controlled substances.  

Source: Aptar Pharma 


Appointments 

ACG Appoints New Sales Director, North America 
ACG, a provider of oral dosage products and services, has appointed Philippe Azzi, formerly Senior Director, Head of Sales and Business Development at SGD Pharma, a provider of glass packaging, as Sales Director for North America. ACG produces capsules, barrier packaging materials, manufacturing machinery, and inspection and traceability products.  

Azzi has more than 30 years’ international sales experience, including 16 years in the pharmaceutical industry. Earlier in his career, he spent more than 15 years with Capsugel, a provider of capsules. His international experience spans Europe, the Middle East, Africa and the Americas. 

Source: ACG